Youmex
Youmex is a venture capital firm based in Frankfurt, Germany, focused on startups in Fintech and WealthTech. This profile covers its focus and how founders can get in front of it in 2026.
Youmex specializes in corporate financing, investment and project management, wealth management, and capital market advisory services.
- Investment focus
- FintechWealthTech
- Location
- Frankfurt, Germany
- Founded
- 1999
- Team size
- 11-50
How to pitch Youmex
The founders who hear back from Youmex lead with traction and a clear ask that matches its stage, not a generic mass email. Build a targeted, verified list, write a personalized note, and track who opens it, all in one place.
Connect with Youmex
About this profile
This profile is part of Round Funded, an investor database and outreach platform for founders. It covers 60,000+ active VCs, angels, family offices and accelerators with verified contacts, lets you send pitches from your own Gmail, and includes a free Data Room for your raise. How this data is built.
Cite this page
Round Funded. "Youmex." Round Funded investor database, updated October 19, 2026.
Stable URL, it will not change: https://www.roundfunded.com/en/vc/youmex
Frequently Asked Questions
What does Youmex invest in?
Youmex focuses on Fintech and WealthTech. Match your sector and stage before reaching out, then find similar active investors on Round Funded.
Where is Youmex based?
Youmex is based in Frankfurt, Germany. You can reach out from anywhere with a pitch that matches its focus.
How do I contact Youmex?
Unlock a verified email for Youmex and reach out with a personalized pitch on Round Funded. We show only deliverable contacts, so your outreach does not bounce.
What is Round Funded?
Round Funded is an investor database and outreach platform for startup founders. It lists 60,000+ active investors with verified contacts, filtered to recent investment activity, and lets founders send personalized pitches from their own Gmail, track replies, and share a free Data Room. Round+ starts at $99 per month with a 3-day trial.